Doxorubicin

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "valueSet" : [ "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168" ]
    } ]
  },
  "date" : "2020-09-02T01:00:24-04:00",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent the medication Doxorubicin.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; injectable Doxorubicin.),(Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.)",
  "name" : "Doxorubicin",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1191138",
      "display" : "doxorubicin hydrochloride 2 MG/ML Injectable Solution",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790095",
      "display" : "doxorubicin hydrochloride 50 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790097",
      "display" : "5 ML doxorubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790099",
      "display" : "10 ML doxorubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790100",
      "display" : "25 ML doxorubicin hydrochloride 2 MG/ML Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1790103",
      "display" : "doxorubicin hydrochloride 10 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1872062",
      "display" : "doxorubicin hydrochloride 20 MG Injection",
      "version" : "11042024"
    } ],
    "total" : 7,
    "identifier" : "urn:uuid:c5606f1a-95e6-4997-a099-1ee6c124c1b3",
    "timestamp" : "2024-12-10T10:12:22-05:00"
  },
  "title" : "Doxorubicin",
  "extension" : [ {
    "valueContactDetail" : {
      "name" : "American Society of Clinical Oncology Author"
    },
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-05-23",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2020-09-02",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "56b3d71a-509e-4d23-a45b-fd8e07afc6ba",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.200",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.1444.5.200"
  } ],
  "version" : "20200902"
}